Pharmacologic Profile of SCH 530348, a Novel Oral Antiplatelet Agent Selective for the Protease-Activated Receptor-1 (PAR-1)

被引：0
|
作者：
Chintala, Madhu [1 ]
Ahn, Ho-Sam [1 ]
Foster, Carolyn [1 ]
Agans, Jacqueline [1 ]
Boykow, George [1 ]
机构：
[1] Schering Plough Rsch Inst, Kenilworth, NJ USA
来源：
CIRCULATION | 2008年 / 118卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S374 / S374
页数：1
相关论文
共 50 条
  • [1] SCH 530348 Is a Novel Oral Antiplatelet Agent Selective for Protease-Activated Receptor-1 (PAR-1) Receptor Subtype Without Partial Agonist Activity
    Chintala, Madhu
    Kurowski, Stan
    Zhai, Ying
    Lachowicz, Jean
    FASEB JOURNAL, 2009, 23
  • [2] Pharmacodynamics and pharmacokinetics of a novel protease-activated receptor (PAR-1) antagonist SCH 530348
    Kosoglou, T
    Reyderman, L
    Fales, RR
    Yang, B
    Keller, R
    Shah, A
    Maxwell, SE
    Veltri, EP
    Cutler, DL
    CIRCULATION, 2005, 112 (17) : U80 - U80
  • [3] Protease-Activated Receptor-1 Antagonists: Focus on SCH 530348
    Sugunaraj, Jaya Prakash
    Mehta, Vimal
    Kalra, Ankur
    Sukhija, Rishi
    Palaniswamy, Chandrasekar
    AMERICAN JOURNAL OF THERAPEUTICS, 2012, 19 (06) : 465 - 469
  • [4] Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer
    Liu, Xuan
    Yu, Jiahui
    Song, Shangjin
    Yue, Xiaoqiang
    Li, Qi
    ONCOTARGET, 2017, 8 (63) : 107334 - 107345
  • [5] Cleavage of protease-activated receptor-1 (PAR-1) and platelet activation by α- and γ-thrombins
    Nyarko, KA
    Freedman, J
    Song, YQ
    Gentry, PA
    Ofosu, FA
    THROMBOSIS AND HAEMOSTASIS, 1999, : 817 - 817
  • [6] De- and resensitization of protease-activated receptor-1 (PAR-1) in rat astrocytes
    Ubl, JJ
    Sergeeva, M
    Reiser, G
    JOURNAL OF NEUROCHEMISTRY, 1999, 73 : S73 - S73
  • [7] Role of protease-activated receptor-1 (PAR-1) in the glomerular filtration barrier integrity
    Medipally, Ajay
    Xiao, Min
    Biederman, Laura
    Satoskar, Anjali A.
    Ivanov, Iouri
    Rovin, Brad
    Parikh, Samir
    Kerlin, Bryce A.
    Brodsky, Sergey, V
    PHYSIOLOGICAL REPORTS, 2022, 10 (15):
  • [8] Protease-activated receptor-1 (PAR-1) expression correlates with a malignant phenotype in human melanoma
    Silini, A.
    Ardinghi, C.
    Carraro, F.
    Naldini, A.
    Bani, M. R.
    Giavazzi, R.
    THROMBOSIS RESEARCH, 2007, 120 : S142 - S143
  • [9] Pregnancy Specific Activation of Neutrophils in Preeclampsia via Protease-Activated Receptor-1 (PAR-1).
    Nugent, William H.
    Teves, Maria E.
    Washington, Sonya L.
    Strauss, Jerome F., III
    Walsh, Scott W.
    REPRODUCTIVE SCIENCES, 2016, 23 : 305A - 305A
  • [10] Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype
    Antonietta Silini
    Carmen Ghilardi
    Camilla Ardinghi
    Sergio Bernasconi
    Paolo Oliva
    Fabio Carraro
    Antonella Naldini
    Maria Rosa Bani
    Raffaella Giavazzi
    Clinical & Experimental Metastasis, 2010, 27 : 43 - 53
12345